Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients
Chandni Patel, Michelle Pasciolla, Rachel Abramova, David M. Salerno, Alexandra Gomez-Arteaga, Tsiporah B. Shore, Nina Orfali, Sebastian Mayer, Jingmei Hsu, Adrienne A. Phillips, Ok-Kyong Chaekal, Michael J. Satlin, Rosemary Soave, Rosy Priya Kodiyanplakkal, Alexander Drelick, Markus Plate, Koen van Besien
Topics & Concepts
AlemtuzumabMedicineRituximabHematopoietic stem cell transplantationCumulative incidenceTransplantationPost-transplant lymphoproliferative disorderInternal medicineImmunologyInterquartile rangeLymphoproliferative disordersGastroenterologyLymphomaViral-associated cancers and disordersPolyomavirus and related diseasesLymphoma Diagnosis and Treatment